|
|
||||||||||
|
J Am Coll Cardiol, 2001; 38:232-237 © 2001 by the American College of Cardiology Foundation |


* Department of Internal Medicine I, School of Medicine, Oita Medical University, Oita, Japan
Department of Laboratory Medicine, School of Medicine, Oita Medical University, Oita, Japan
Manuscript received December 1, 2001; revised manuscript received March 21, 2001, accepted April 5, 2001.
Reprint requests and correspondence: Dr. Naohiko Takahashi, Department of Internal Medicine I, School of Medicine, Oita Medical University, 1-1 Idaigaoka, Hasama, Oita 879-5593, Japan
takanao{at}oita-med.ac.jp
OBJECTIVES
The aim of this study was to examine the effects of essential hypertension on cardiac autonomic function in type 2 diabetic patients.
BACKGROUND
Hypertension is common in type 2 diabetic patients and is associated with a high mortality. However, the combined effects of type 2 diabetes and essential hypertension on cardiac autonomic function have not been fully elucidated.
METHODS
Thirty-three patients with type 2 diabetes were assigned to a hypertensive diabetic group (n = 15; age: 56 ± 8 years, mean ± SD) or an age-matched normotensive diabetic group (n = 18, 56 ± 6 years). Cardiac autonomic function was assessed by baroreflex sensitivity (BRS), heart rate variability (HRV), plasma norepinephrine concentration and cardiac 123I-metaiodobenzylguanidine (MIBG) scintigraphic findings.
RESULTS
Baroreflex sensitivity was lower in the hypertensive diabetic group than it was in the normotensive diabetic group (p < 0.05). The early and delayed myocardial uptake of 123I-MIBG was lower (p < 0.01 and p < 0.05, respectively), and the percent washout rate of 123I-MIBG was higher (p < 0.05) in the hypertensive diabetic group. However, the high frequency (HF) power and the ratio of low frequency (LF) power to HF power (LF/HF) of HRV and plasma norepinephrine concentration were not significantly different. The homeostasis model assessment index was higher in the hypertensive diabetic group than it was in the normotensive diabetic group (p < 0.01).
CONCLUSIONS
Our results indicate that essential hypertension acts synergistically with type 2 diabetes to depress cardiac reflex vagal and sympathetic function, and the results also suggest that insulin resistance may play a pathogenic role in these processes.
| ||||||||||||||||||||||||
This article has been cited by other articles:
![]() |
Z. Y. Fang, J. B. Prins, and T. H. Marwick Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications Endocr. Rev., August 1, 2004; 25(4): 543 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. GOLDSTEIN Functional Neuroimaging of Sympathetic Innervation of the Heart Ann. N.Y. Acad. Sci., June 1, 2004; 1018(1): 231 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Huggett, E. M. Scott, S. G. Gilbey, J. B. Stoker, A. F. Mackintosh, and D. A.S.G. Mary Impact of Type 2 Diabetes Mellitus on Sympathetic Neural Mechanisms in Hypertension Circulation, December 23, 2003; 108(25): 3097 - 3101. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |